Webinar – Integrated mRNA & circRNA-tLNP Platform Empowering In Vivo CAR-T Therapies Register Now RNA therapeutics and targeted lipid nanoparticles (tLNP) are opening new possibilities for engineering CAR-T cells directly in the body. How can integrated platforms accelerate this innovation? Join our upcoming webinar, discover how combining plasmid development, RNA manufacturing, and targeted LNP delivery can simplify and speed up the journey from concept to therapeutic application. Lauren LuSr. Director, Plasmid Business Dept., ProBio Wei GuoSr. Manager, mRNA PD, ProBio Time Topic 14:00-14:40 Development and Manufacturing Strategy for mRNA Template PlasmidsDr. Lauren Lu, Sr. Director, Plasmid Business Dept., ProBio Understand the challenge of mRNA template plasmids production Develop proprietary strains, backbone, and robust production process for mRNA template plasmids Gain insight into industry trends, challenges & opportunities in the sector 14:40-15:20 Integrated xRNA-tLNP Platform Empowering In Vivo CAR-T TherapiesDr. Wei Guo, Sr. Manager, mRNA PD Dept., ProBio Key considerations of xRNA–LNP technology for CAR-T therapy Technical challenges and solutions to xRNA-tLNP manufacturing Case study of in vivo CAR-T Related service: RNA-tLNP One-Stop Solution, In Vivo CAR-T Discovery, LVV Drug Product One-Stop Solution, Antibody & Protein CMC Solutions for CGT Available materials « Previous Page ProBio Announces New Executive Appointments Next Page ProBio Accelerates Chimagen's Global Market Expansion, Paving the Way for Innovative Antibody Therapy » Contact us Phone: 1-877-436-7274 (Toll-Free); 1-732-885-9188 Fax: 1-732-210-0262
Latest WebinarsWebinar – Integrated mRNA & circRNA-tLNP Platform Empowering In Vivo CAR-T TherapiesAccelerating In Vivo CAR-T Antibody Discovery and Development | ProBio CDMOsdAb Discovery & ExpressCMC™ with Cell Line Development Webinar | ProBio CDMOBiologics Webinar: From Lab Bench to GMP for BsAb & ADC | ProBio CDMOFind More Therapeutic Antibody Categories